Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,492,587
Closed -$70.1M 2250
2016
Q4
$70.1M Sell
2,492,587
-3,909,596
-61% -$110M 0.03% 536
2016
Q3
$150M Buy
6,402,183
+2,473,321
+63% +$58M 0.07% 267
2016
Q2
$85.1M Buy
+3,928,862
New +$85.1M 0.04% 442
2014
Q3
Sell
-9,707,230
Closed -$235M 2358
2014
Q2
$235M Buy
9,707,230
+4,853,615
+100% +$118M 0.06% 287
2014
Q1
$102M Sell
4,853,615
-111,512
-2% -$2.34M 0.06% 317
2013
Q4
$116M Sell
4,965,127
-48,271
-1% -$1.13M 0.07% 280
2013
Q3
$108M Sell
5,013,398
-187,362
-4% -$4.04M 0.06% 302
2013
Q2
$102M Buy
+5,200,760
New +$102M 0.06% 294

Other funds holding QGENF

Norges Bank's QGENF Position: Q1 2017 in Review

Norges Bank sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 2,492,587 shares — an estimated $70.1M sold.

Norges Bank first reported a position in QGENF in Q2 2013 and held it in 8 quarters. The position peaked at $235M in Q2 2014. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Norges Bank reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Norges Bank sold 2,492,587 QIAGEN NV shares in Q1 2017, an estimated $70.1M.
  • Norges Bank first reported a position in QIAGEN NV in Q2 2013 and held it in 8 quarters.
  • Norges Bank's QIAGEN NV position peaked at $235M in Q2 2014.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Norges Bank's 13F filing for Q1 2017, filed 10 May 2017.